PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 106 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 3.94 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $380 | -26.9% | 123 | 0.0% | 0.00% | – |
Q4 2022 | $520 | – | 123 | 0.0% | 0.00% | – |
Q3 2022 | $0 | – | 123 | 0.0% | 0.00% | – |
Q2 2022 | $0 | – | 123 | 0.0% | 0.00% | – |
Q1 2022 | $0 | – | 123 | +66.2% | 0.00% | – |
Q4 2019 | $0 | – | 74 | 0.0% | 0.00% | – |
Q3 2019 | $0 | -100.0% | 74 | -99.9% | 0.00% | -100.0% |
Q2 2019 | $1,518,000 | -74.2% | 119,464 | -21.2% | 0.00% | -83.3% |
Q1 2019 | $5,879,000 | – | 151,586 | +2526333.3% | 0.01% | – |
Q1 2018 | $0 | – | 6 | 0.0% | 0.00% | – |
Q4 2017 | $0 | -100.0% | 6 | -99.3% | 0.00% | – |
Q2 2017 | $77,000 | +108.1% | 880 | -12.0% | 0.00% | – |
Q1 2017 | $37,000 | +19.4% | 1,000 | 0.0% | 0.00% | – |
Q4 2016 | $31,000 | +416.7% | 1,000 | +900.0% | 0.00% | – |
Q3 2016 | $6,000 | 0.0% | 100 | -50.0% | 0.00% | – |
Q1 2016 | $6,000 | -62.5% | 200 | 0.0% | 0.00% | – |
Q4 2015 | $16,000 | -87.2% | 200 | -88.0% | 0.00% | – |
Q3 2015 | $125,000 | -39.3% | 1,666 | -5.6% | 0.00% | – |
Q2 2015 | $206,000 | +82.3% | 1,764 | +264.5% | 0.00% | – |
Q1 2015 | $113,000 | +79.4% | 484 | +48.0% | 0.00% | – |
Q4 2014 | $63,000 | +103.2% | 327 | +151.5% | 0.00% | – |
Q3 2014 | $31,000 | +520.0% | 130 | +85.7% | 0.00% | – |
Q2 2014 | $5,000 | -66.7% | 70 | -52.1% | 0.00% | – |
Q1 2014 | $15,000 | -81.2% | 146 | -92.0% | 0.00% | – |
Q2 2013 | $80,000 | – | 1,820 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARVARD MANAGEMENT CO INC | 600,000 | $45,216,000 | 3.56% |
Avalon Global Asset Management LLC | 32,900 | $2,479,000 | 1.79% |
CORNERSTONE CAPITAL MANAGEMENT LLC | 495,145 | $37,314,000 | 1.58% |
BB BIOTECH AG | 521,991 | $39,337,000 | 1.25% |
WEATHERBIE CAPITAL, LLC | 137,041 | $10,327,000 | 1.20% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $428,527,000 | 1.19% |
TOBAM | 318,384 | $23,994,000 | 0.94% |
Orbimed Advisors | 1,195,500 | $90,093,000 | 0.91% |
Capital International Sarl | 109,405 | $8,245,000 | 0.74% |
CAPITAL INTERNATIONAL LTD /CA/ | 145,697 | $10,980,000 | 0.73% |